CV Sciences (CVSI) Cash & Equivalents Growth (1y) (2011 - 2026)
CV Sciences (CVSI) Cash & Equivalents Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | 69.13% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | 2.86% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 19.56% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 13.19% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 56.51% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 25.91% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | -1.67% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | -4.65% |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | -69.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -69.98% |
| Mar 31, 2026 | -61.95% |
| Dec 31, 2025 | -38.77% |
| Sep 30, 2025 | -61.08% |
| Jun 30, 2025 | 85.74% |
| Mar 31, 2025 | 22.66% |
| Dec 31, 2024 | -65.53% |
| Sep 30, 2024 | -40.41% |
| Jun 30, 2024 | -71.78% |
| Mar 31, 2024 | -7.28% |
| Dec 31, 2023 | 115.55% |
| Sep 30, 2023 | 44.25% |
| Jun 30, 2023 | 51.71% |
| Mar 31, 2023 | -70.73% |
| Dec 31, 2022 | -55.56% |
| Jun 30, 2022 | -54.72% |
| Mar 31, 2022 | -52.78% |
| Dec 31, 2021 | -65.83% |
| Dec 31, 2020 | 0.60% |
| Dec 31, 2019 | 1,233.33% |